Advanced Proteome Therapeutics Corporation reported earnings results for the full year ended July 31, 2022. For the full year, the company reported net income was USD 0.759615 million compared to net loss of USD 1.83 million a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to basic loss per share from continuing operations of USD 0.06 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 151K | |
+191.37% | 6.97B | |
+5.09% | 1.04B | |
+2.10% | 982M | |
+41.91% | 872M | |
+24.45% | 814M | |
+10.41% | 675M | |
+1.72% | 664M | |
-.--% | 600M | |
+3.61% | 503M |
- Stock Market
- Equities
- APC.H Stock
- News Advanced Proteome Therapeutics Corporation
- Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022